ROCHESTER, N.Y. and
PRINCETON, N.J., March 13, 2018 /PRNewswire/ -- GRYT Health, a
connected health start-up with a social purpose, and Bristol-Myers
Squibb Company (NYSE: BMY) today announced a strategic pilot
utilizing de-identified data to integrate patient insights and
clinical research with the goal of building a foundation of
real-world data that will support improved clinical trial design,
disease management and the overall well-being of patients living
with cancer.
The pilot will provide Bristol-Myers Squibb with valuable
insights from patients on their experiences with cancer through
GRYT's Stupid Cancer app, the most used patient and caregiver
platform in oncology. The app is designed to instantly and
anonymously connect people affected by cancer with each other, give
them a platform for exchange and empower them with important
resources and information. By learning more about how patients
experience and manage their disease, Bristol-Myers Squibb and GRYT
aim to accelerate health innovations and improve quality of life
for patients.
"This pilot represents a shared commitment between GRYT Health
and Bristol-Myers Squibb to improve the lives of patients through
collaboration and digital innovation," said Dave Fuehrer, co-founder and CEO of GRYT Health.
"We worked with patients to build the Stupid Cancer app around
their unique preferences and expectations. Together with
Bristol-Myers Squibb, we are taking the same patient-driven
approach to accelerate progress in the way we manage disease and
support the overall well-being for patients impacted by
cancer."
"Our primary focus is always on the patient," said Murdo Gordon, chief commercial officer,
Bristol-Myers Squibb. "Through our collaboration with GRYT, we have
the opportunity to incorporate the input of cancer patients across
our business – from research to patient support and empowerment
programs – that will best serve the cancer community."
"Today's technology has the potential to help us begin to close
the gap between patient experience and cancer research," said
Kate Owen, head of clinical
operations, Bristol-Myers Squibb. "Through the Stupid Cancer app,
we are excited to learn more from patients about how we can make
our clinical research programs as patient-friendly as
possible."
Stupid Cancer's App is a free mobile app that provides instant,
anonymous peer support and targeted cancer information to anyone
affected by cancer including patients, survivors, caregivers,
friends, family, medical professionals, researchers and advocates.
Users complete a short profile and are connected with others based
on the similarity of their experience. They can also participate in
moderated group chats and programs hosted by experts in their
field. Stupid Cancer's App is available for free download for
iOS devices and for Android in April
2018.
At the 2018 SXSW Interactive Festival, GRYT Health was
recognized as a runner-up in the HealthSpark Barracuda Bowl, a
"shark tank" like pitch competition for innovative startups. GRYT
was also selected as runner-up for the Cambridge Healthtech
Institute (CHI)'s 2018 Summit for Clinical Ops Executives (SCOPE)
award, recognizing innovation and change in how the industry
communicates with participants in the fields of recruitment and
retention in clinical trials.
About GRYT Health
GRYT Health is a Connected Health start-up with a social purpose.
Founded in 2016 by cancer survivors and caregivers, GRYT developed
the Stupid Cancer app, a web-based mobile platform that is used in
all 50 states and across 50 countries, to connect people with
others just like them and with information to manage their health
on their terms. GRYT works with organizations who specialize in
oncology to ensure people have information and access to options,
so they can choose what's right for them. Ten percent of GRYT's
revenue is donated to Stupid Cancer, the leading advocacy
organization supporting adolescents and young adults affected by
cancer. GRYT is headquartered in Rochester, NY. For more information, visit
www.grythealth.com.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global
biopharmaceutical company whose mission is to discover, develop and
deliver innovative medicines that help patients prevail over
serious diseases. For more information, please
visit www.bms.com or follow us on Twitter
at http://twitter.com/bmsnews.
CONTACT:
BRISTOL-MYERS SQUIBB
Media:
Danielle Halstrom, 215-280-3898
danielle.halstrom@bms.com
GRYT HEALTH
Media:
Vikki Christian, 424-610-1241
vikki@grythealth.com
View original
content:http://www.prnewswire.com/news-releases/gryt-health-and-bristol-myers-squibb-announce-new-digital-pilot-to-advance-cancer-care-through-patient-driven-insights-300612836.html
SOURCE GRYT Health